Global pharmaceutical companies are entering 2026 facing an escalating dispute over drug pricing in Europe. After agreeing to lower prescription prices in the United States under pressure from President Donald Trump in late 2025, manufacturers are seeking to recover revenues by pushing for higher prices in European markets. – Reuters (8 Jan 2026)
On 8 January the National Consumer Commission (NCC) issued an urgent warning over a specific batch of Nestle infant formula. That means SA parents need to return tins of contaminated NAN infant formula.
The Spar Group plans to expand its pharmacy front-shop offering by introducing a "bespoke wellness concept", reported Business Times (14 December 2025)
Government has decided to intervene following the 9.8% tariff increase announced in 2025 by Government Employees Medical Scheme (GEMS). – Business Day (8 Jan 2026) Officials will engage with the scheme’s Board of Trustees regarding the "unaffordable tariffs".